Depression and Anxiety Trial, Not Yet Recruiting NCT07639827 Sponsor: Massachusetts General Hospital Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Not Yet Recruiting

NCT07639827
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are currently a fourth-year anesthesiology resident (PGY4) at Massachusetts General Hospital or Brigham and Women's Hospital.
  • People who are willing to give their informed consent to participate.
  • Each resident may choose one person close to them — such as a partner, family member, friend, or other loved one — to also take part in the study.
  • The decision of who to name as a loved one participant is left entirely to the resident.
  • Only one loved one per resident is eligible to take part.
  • Residents are still eligible to take part even if they do not name a loved one.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are not able to complete questionnaires written in English.
  • People who are not able to use the study's digital tools, such as a smartphone app or website platform.
  • People who are under 18 years of age.
  • People who are currently taking part in another research study that is also focused on mental fitness or wellbeing.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 201-421-7864

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2026
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Recruitment Rate; Dyadic Enrollment Rate; Retention Rate; Adherence; Intervention Acceptability (Acceptability of Intervention Measure, AIM); Intervention Appropriateness (Intervention Appropriateness Measure, IAM); Intervention Feasibility (Feasibility of Intervention Measure, FIM); Net Promoter Score (NPS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov